What letting RFK Jr. ‘go wild’ might mean for Trump’s FDA

With Donald Trump’s victory in the presidential election, public health experts are anxiously waiting to see whether his embrace of Robert F. Kennedy Jr. will translate into real policy, and perhaps chaos, at the Food and Drug Administration — the regulator tasked with ensuring that America’s drugs are effective and its food is safe to eat.

In the weeks leading up to the election, Trump promised supporters that he would give RFK Jr. an important role in his administration and let him “go wild” on health care.

advertisement

 In his victory speech, the president-elect name-checked Kennedy again. “He’s going to help make America healthy again,” Trump said. “He’s a great guy and he really means it. He wants to do some things, and we’re gonna let him go to it.”

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe